The Battle with COVID-19: Insight on External Intervention and Future Vaccination

References (78)

1. 1 Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus [DOI]
2. 2 Chloroquine is a potent inhibitor of SARS coronavirus infection and spread [DOI]
3. 3 Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys [DOI]
4. 4 SARS: Systematic Review of Treatment Effects [DOI]
5. 5 Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase [DOI]
6. 6 Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies [DOI]
7. 7 In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine [DOI]
8. 8 Chamomile (Matricaria chamomilla L.): An overview [DOI]
9. 9 Zingiberis rhizoma: A comprehensive review on the ginger effect and efficacy profiles [DOI]
10. 10 Hydroxychloroquine: From Malaria to Autoimmunity [DOI]
11. 11 Mechanisms of action of ribavirin against distinct viruses [DOI]
12. 12 Effects of a ginger extract on knee pain in patients with osteoarthritis [DOI]
13. 13 Comparative study on the antiviral activity of selected monoterpenes derived from essential oils [DOI]
14. 14 Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model [DOI]
15. 15 IL-6 biology: implications for clinical targeting in rheumatic disease [DOI]
16. 16 Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate [DOI]
17. 17 The Predominant Mechanism by Which Ribavirin Exerts Its Antiviral Activity In Vitro against Flaviviruses and Paramyxoviruses Is Mediated by Inhibition of IMP Dehydrogenase [DOI]
18. 18 Lopinavir/ritonavir in the treatment of HIV-1 infection: a review [DOI]
19. 19 Inhibitory effect of essential oils against herpes simplex virus type 2 [DOI]
20. 20 Corticosteroid-related central nervous system side effects [DOI]
21. 21 Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials [DOI]
22. 22 Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted [DOI]
23. 23 Susceptibility of Drug-Resistant Clinical Herpes Simplex Virus Type 1 Strains to Essential Oils of Ginger, Thyme, Hyssop, and Sandalwood [DOI]
24. 24 In Vitro Antiviral Activity of Cinnamomum cassia and Its Nanoparticles Against H7N3 Influenza A Virus [DOI]
25. 25 Intravenous immunoglobulin therapy in rheumatic diseases [DOI]
26. 26 Favipiravir: A New Medication for the Ebola Virus Disease Pandemic [DOI]
27. 27 Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy [DOI]
28. 28 A review of the traditional and modern uses of Salvadora persica L. (Miswak): Toothbrush tree of Prophet Muhammad [DOI]
29. 29 Vaccines for the prevention against the threat of MERS-CoV [DOI]
30. 30 Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA [DOI]
31. 31 Inhibition of viral proteases by Zingiberaceae extracts and flavones isolated from Kaempferia parviflora.
32. 32 Hydroxychloroquine: A Physiologically-Based Pharmacokinetic Model in the Context of Cancer-Related Autophagy Modulation [DOI]
33. 33 The potential place of chloroquine in the treatment of HIV-1-infected patients [DOI]
34. 34 Chemical composition and antifungal effect of anise (Pimpinella anisum L.) fruit oil at ripening stage [DOI]
35. 35 Dose-dependent pharmacokinetics of dexamethasone [DOI]
36. 36 Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans [DOI]
37. 37 Dexamethasone metabolism in vitro: Species differences [DOI]
38. 38 Antibacterial, Antiviral and Antifungal Activity of Essential Oils: Mechanisms and Applications [DOI]
39. 39 Characterization of chloroquine plasma protein binding in man. [DOI]
40. 40 Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen [DOI]
41. 41 Molecular approaches for the treatment of hemorrhagic fever virus infections [DOI]
42. 42 Mechanism of La Crosse virus inhibition by ribavirin [DOI]
43. 43 The effect of an extract of Salvadora persica (Meswak, chewing stick) on fertility of male and female mice [DOI]
44. 44 Respiratory syncytial virus: Update on infection, treatment, and prevention [DOI]
45. 45 HIV protease inhibitors [DOI]
46. 46 PRELIMINARY COMPARATIVE ANALYSIS OF FOUR BOTANICALS USED IN THE TRADITIONAL MEDICINES OF PAKISTAN
47. 47 Nutraceuticals in Glucose Balance and Diabetes [DOI]
48. 48 Technology evaluation: MRA, Chugai.
49. 49 Antivirals for the chemoprophylaxis and treatment of influenza.
50. 50 Mabberley's plant-book: a portable dictionary of plants, their classification and uses [DOI]
51. 51 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
52. 52 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [DOI]
53. 53 Antibody responses to SARS-CoV-2 in patients with COVID-19 [DOI]
54. 54 Effective treatment of severe COVID-19 patients with tocilizumab [DOI]
55. 55 Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies [DOI]
56. 56 Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion [DOI]
57. 57 Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients [DOI]
58. 58 Virology, Epidemiology, Pathogenesis, and Control of COVID-19 [DOI]
59. 59 Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [DOI]
60. 60 Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective [DOI]
61. 61 Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir [DOI]
62. 62 COVID-19: A promising cure for the global panic [DOI]
63. 63 High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019 [DOI]
64. 64 Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor [DOI]
65. 65 A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia [DOI]
66. 66 Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective [DOI]
67. 67 Handbook of herbs and spices [DOI]
68. 68 Influenza virus polymerase inhibitors in clinical development [DOI]
69. 69 Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study [DOI]
70. 70 Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases [DOI]
71. 71 Clinical outcomes of current medical approaches for Middle East respiratory syndrome: A systematic review and meta‐analysis [DOI]
72. 72 Prospects for a MERS-CoV spike vaccine [DOI]
73. 73 Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients [DOI]
74. 74 Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab [DOI]
75. 75 Use of hydroxychloroquine and interferon alpha-2b for the prophylaxis of COVID-19 [DOI]
76. 76 Hepatitis C Virus Infection in Pregnancy: An Update [DOI]
77. 77 Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial [DOI]
78. 78 Dexamethasone Injection [DOI]

Cited by 2

Related research

• COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
• Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
• Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
• Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
• Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage